[1] [1] BERTRAN E, HEISE K, ANDIA M E, et al. Gallbladder cancer: Incidence and survival in a high-risk area of Chile[J]. International Journal of Cancer, 2010, 127(10): 2446-2454.

[2] [2] MALATS N, REAL F X. Epidemiology of bladder cancer[J]. Oncology Clinics of North America, 2015, 29(2): 177-189.

[3] [3] CLARK P E. Bladder cancer[J]. Journal of the National Comprehensive Cancer Network Jnccn, 2007, 11(4):446.

[4] [4] ZHANG K Y, XING J C, LI W, et al. A novel transurethral resection technique for superficial bladder tumor: Retrograde en bloc resection[J]. World Journal of Surgical Oncology, 2017, 15(1): 125.

[5] [5] KRAMER M W, RASSWEILER J J, KLEIN J, et al. En bloc resection of urothelium carcinoma of the bladder (EBRUC): A European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor[J]. World Journal of Urology, 2015, 33(12): 1937-1943.

[6] [6] BLAN G X, GEAVLETE P A, GEORGESCU D A, et al. Bipolar en bloc tumor resection versus standard monopolar TURBT-which is the best way to go in non-invasive bladder cancer?[J]. Romanian Journal of Morphology and Embryology, 2018, 59(3): 773-780.

[7] [7] GEAVLETE B, MULTESCU R, GEORGESCU D, et al. Bipolar en bloc tumor resection versus standard monopolar TURBT in non-muscle invasive bladder cancer-a medium-term, prospective, randomized-controlled comparison[J]. European Urology Supplements, 2019, 18(1): e761.

[8] [8] HURLE R, LAZZERI M, COLOMBO P, et al. “En bloc” resection of nonmuscle invasive bladder cancer: A prospective single-center study[J]. Urology, 2016, 90: 126-130.

[9] [9] TENG L C, LI C F, WANG W T, et al. Initial experience with surrounding en bloc transurethral resection of bladder tumor and simultaneous intravesical treating for non-muscle invasive bladder cancer[J]. BMC Urology, 2022, 22(1): 189.

[11] [11] CHEN X, LIAO J, CHEN L W, et al. En bloc transurethral resection with 2-micron continuous-wave laser for primary non-muscle-invasive bladder cancer: A randomized controlled trial[J]. World Journal of Urology, 2015, 33(7): 989-995.

[13] [13] FU J H, FU F J, WANG Y H. 1 470 nm/980 nm dual-wavelength laser is safe and efficient for the en-bloc resection of non-muscle invasive bladder cancer: A propensity score-matched analysis[J]. Journal of International Medical Research, 2021, 49(12): 030006052110653.

[16] [16] ZHANG W Q, ZHOU B, DENG J, et al. Retrospective analysis of 1470-/980-nm dual-wavelength laser en bloc resection versus transurethral resection of bladder tumor for primary non-muscle-invasive bladder cancer[J]. Lasers in Medical Science, 2023, 38(1): 44.

[17] [17] GAKIS G, KARL A, BERTZ S, et al. Transurethral en-bloc hydrodissection for non-muscle invasive bladder cancer: Results of a randomized controlled trial[J]. European Urology Supplements, 2017, 16(3): e1143-e1144.

[18] [18] ISLAS-GARCA J J O, CAMPOS-SALCEDO J G, LPEZ-BENJUME, B I,et al.Surgical technique for en bloc transurethral resection of bladder tumour with a Hybrid Knife[J].Actas Urologicas Espanolas, 2016, 40(4): 263-267.

[19] [19] CHENG Y Y, SUN Y, LI J, et al. Transurethral endoscopic submucosal en bloc dissection for nonmuscle invasive bladder cancer: A comparison study of HybridKnife-assisted versus conventional dissection technique[J]. Journal of Cancer Research and Therapeutics, 2018, 14(7): 1606-1612.

[20] [20] BOLLIGER M, KROEHNERT J A, MOLINEUS F, et al. Experiences with the standardized classification of surgical complications (Clavien-Dindo) in general surgery patients[J]. European Surgery, 2018, 50(6): 256-261.

[21] [21] SCHRAML J, DO CARMO SILVA J, BABJUK M. Current concept of transurethral resection of bladder cancer: From re-transurethral resection of bladder cancer to en-bloc resection[J]. Current Opinion in Urology, 2018, 28(6): 591-597.

[22] [22] HERRMANN T R W, WOLTERS M, KRAMER M W. Transurethral en bloc resection of nonmuscle invasive bladder cancer[J]. Current Opinion in Urology, 2017, 27(2): 182-190.

[23] [23] KRAMER M W, ALTIERI V, HURLE R, et al. Current evidence of transurethral en-bloc resection of nonmuscle invasive bladder cancer[J]. European Urology Focus, 2017, 3(6): 567-576.

[24] [24] STAEHLER G, SCHMIEDT E, HOFSTETTER A. Destruction of bladder neoplasms by means of transurethral neodym-YAG-laser coagulation[J]. Helvetica Chirurgica Acta, 1978, 45(3): 307-311.

[25] [25] GAO W B. Current opinions regarding the clinical utility of en bloc resection in the treatment of non-muscle invasive bladder cancer-a review of the literature[J]. Discover Oncology, 2024, 15(1): 574.

[26] [26] HASHEM A, MOSBAH A, EL-TABEY N A, et al. Holmium laser en-bloc resection versus conventional transurethral resection of bladder tumors for treatment of non-muscle-invasive bladder cancer: A randomized clinical trial[J]. European Urology Focus, 2021, 7(5): 1035-1043.

[27] [27] WOLTERS M, KRAMER M W, BECKER J U, et al. Tm: YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: Early experience[J]. World Journal of Urology, 2011, 29(4): 429-432.

[28] [28] LU YL, JIANG S N, YIN X T, et al. Long-term effect of transurethral partial cystectomy with a 2-micrometer continuous-wave laser for non-muscle-invasive bladder cancer[J]. Frontiers in Surgery, 2023, 10: 1117997.

[29] [29] EROL A, CAM K, TEKIN A, et al. High power diode laser vaporization of the prostate: Preliminary results for benign prostatic hyperplasia[J]. The Journal of Urology, 2009, 182(3): 1078-1082.

[33] [33] AKAND M, MUILWIJK T, RASKIN Y, et al. Quality control indicators for transurethral resection of non-muscle-invasive bladder cancer[J]. Clinical Genitourinary Cancer, 2019, 17(4): e784-e792.

[35] [35] TEOH J Y C, MACLENNAN S, CHAN V W S, et al. An international collaborative consensus statement on en bloc resection of bladder tumour incorporating two systematic reviews, a two-round Delphi survey, and a consensus meeting[J]. European Urology, 2020, 78(4): 546-569.

[36] [36] BASILE G, ULERI A, LENI R, et al.En bloc versus conventional transurethral resection of bladder tumors: A systematic review and meta-analysis of oncological, histopathological, and surgical outcomes[J]. European Urology Oncology, 2024: S2588-S9311(24)00232-3.